nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0363	0.0433	CbGbCtD
Carbinoxamine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0341	0.0407	CbGbCtD
Carbinoxamine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0341	0.0407	CbGbCtD
Carbinoxamine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0309	0.0368	CbGbCtD
Carbinoxamine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0259	0.0309	CbGbCtD
Carbinoxamine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0237	0.0283	CbGbCtD
Carbinoxamine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0234	0.0279	CbGbCtD
Carbinoxamine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0234	0.0279	CbGbCtD
Carbinoxamine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0234	0.0279	CbGbCtD
Carbinoxamine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0231	0.0275	CbGbCtD
Carbinoxamine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0217	0.0259	CbGbCtD
Carbinoxamine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0196	0.0234	CbGbCtD
Carbinoxamine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0196	0.0234	CbGbCtD
Carbinoxamine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0192	0.0229	CbGbCtD
Carbinoxamine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.018	0.0215	CbGbCtD
Carbinoxamine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.018	0.0215	CbGbCtD
Carbinoxamine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0177	0.0211	CbGbCtD
Carbinoxamine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0177	0.0211	CbGbCtD
Carbinoxamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0175	0.0209	CbGbCtD
Carbinoxamine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.017	0.0203	CbGbCtD
Carbinoxamine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0169	0.0202	CbGbCtD
Carbinoxamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0165	0.0197	CbGbCtD
Carbinoxamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0165	0.0197	CbGbCtD
Carbinoxamine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0164	0.0196	CbGbCtD
Carbinoxamine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0163	0.0195	CbGbCtD
Carbinoxamine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0163	0.0195	CbGbCtD
Carbinoxamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0149	0.0178	CbGbCtD
Carbinoxamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0149	0.0178	CbGbCtD
Carbinoxamine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0149	0.0177	CbGbCtD
Carbinoxamine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0149	0.0177	CbGbCtD
Carbinoxamine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0142	0.017	CbGbCtD
Carbinoxamine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0141	0.0168	CbGbCtD
Carbinoxamine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0137	0.0163	CbGbCtD
Carbinoxamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0129	0.0154	CbGbCtD
Carbinoxamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0125	0.0149	CbGbCtD
Carbinoxamine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0124	0.0148	CbGbCtD
Carbinoxamine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0124	0.0148	CbGbCtD
Carbinoxamine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0118	0.0141	CbGbCtD
Carbinoxamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0113	0.0135	CbGbCtD
Carbinoxamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0113	0.0135	CbGbCtD
Carbinoxamine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0111	0.0133	CbGbCtD
Carbinoxamine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0105	0.0125	CbGbCtD
Carbinoxamine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0105	0.0125	CbGbCtD
Carbinoxamine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00948	0.0113	CbGbCtD
Carbinoxamine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00948	0.0113	CbGbCtD
Carbinoxamine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00818	0.00977	CbGbCtD
Carbinoxamine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00794	0.00948	CbGbCtD
Carbinoxamine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00718	0.00858	CbGbCtD
Carbinoxamine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00718	0.00858	CbGbCtD
Carbinoxamine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00689	0.00822	CbGbCtD
Carbinoxamine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00118	0.0647	CbGeAlD
Carbinoxamine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0565	CbGeAlD
Carbinoxamine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000922	0.0506	CbGeAlD
Carbinoxamine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000913	0.0502	CbGeAlD
Carbinoxamine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000865	0.0475	CbGeAlD
Carbinoxamine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000696	0.0382	CbGeAlD
Carbinoxamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000685	0.0376	CbGeAlD
Carbinoxamine—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.000477	0.00331	CcSEcCtD
Carbinoxamine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000477	0.00331	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000476	0.0033	CcSEcCtD
Carbinoxamine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000476	0.0033	CcSEcCtD
Carbinoxamine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000469	0.00325	CcSEcCtD
Carbinoxamine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000466	0.00323	CcSEcCtD
Carbinoxamine—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000464	0.00322	CcSEcCtD
Carbinoxamine—Tremor—Indinavir—acquired immunodeficiency syndrome	0.000463	0.00321	CcSEcCtD
Carbinoxamine—Chills—Delavirdine—acquired immunodeficiency syndrome	0.000461	0.00319	CcSEcCtD
Carbinoxamine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00046	0.00319	CcSEcCtD
Carbinoxamine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000459	0.00318	CcSEcCtD
Carbinoxamine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000459	0.00318	CcSEcCtD
Carbinoxamine—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000458	0.00318	CcSEcCtD
Carbinoxamine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000454	0.00315	CcSEcCtD
Carbinoxamine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000454	0.00314	CcSEcCtD
Carbinoxamine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000453	0.00314	CcSEcCtD
Carbinoxamine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000453	0.0249	CbGeAlD
Carbinoxamine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000453	0.00314	CcSEcCtD
Carbinoxamine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000452	0.00314	CcSEcCtD
Carbinoxamine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00313	CcSEcCtD
Carbinoxamine—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000449	0.00312	CcSEcCtD
Carbinoxamine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000449	0.00311	CcSEcCtD
Carbinoxamine—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000448	0.00311	CcSEcCtD
Carbinoxamine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000446	0.00309	CcSEcCtD
Carbinoxamine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000445	0.00308	CcSEcCtD
Carbinoxamine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000445	0.00308	CcSEcCtD
Carbinoxamine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000444	0.00308	CcSEcCtD
Carbinoxamine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000444	0.00307	CcSEcCtD
Carbinoxamine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000443	0.0243	CbGeAlD
Carbinoxamine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.000443	0.00307	CcSEcCtD
Carbinoxamine—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000441	0.00306	CcSEcCtD
Carbinoxamine—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000441	0.00305	CcSEcCtD
Carbinoxamine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00044	0.00305	CcSEcCtD
Carbinoxamine—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000439	0.00304	CcSEcCtD
Carbinoxamine—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000438	0.00304	CcSEcCtD
Carbinoxamine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000437	0.00303	CcSEcCtD
Carbinoxamine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000437	0.00303	CcSEcCtD
Carbinoxamine—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000437	0.00303	CcSEcCtD
Carbinoxamine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00302	CcSEcCtD
Carbinoxamine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000434	0.00301	CcSEcCtD
Carbinoxamine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000434	0.00301	CcSEcCtD
Carbinoxamine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000431	0.0237	CbGeAlD
Carbinoxamine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000431	0.00299	CcSEcCtD
Carbinoxamine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00043	0.00298	CcSEcCtD
Carbinoxamine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000429	0.00297	CcSEcCtD
Carbinoxamine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000427	0.00296	CcSEcCtD
Carbinoxamine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000427	0.00296	CcSEcCtD
Carbinoxamine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000426	0.00295	CcSEcCtD
Carbinoxamine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.000426	0.00295	CcSEcCtD
Carbinoxamine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.000426	0.00295	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000425	0.00294	CcSEcCtD
Carbinoxamine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000424	0.00294	CcSEcCtD
Carbinoxamine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000421	0.00292	CcSEcCtD
Carbinoxamine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00291	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000419	0.00291	CcSEcCtD
Carbinoxamine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000419	0.0029	CcSEcCtD
Carbinoxamine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000413	0.00287	CcSEcCtD
Carbinoxamine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000413	0.00286	CcSEcCtD
Carbinoxamine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000412	0.00286	CcSEcCtD
Carbinoxamine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000412	0.00286	CcSEcCtD
Carbinoxamine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.00285	CcSEcCtD
Carbinoxamine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000411	0.00285	CcSEcCtD
Carbinoxamine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00041	0.00284	CcSEcCtD
Carbinoxamine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000405	0.00281	CcSEcCtD
Carbinoxamine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000405	0.00281	CcSEcCtD
Carbinoxamine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000405	0.0028	CcSEcCtD
Carbinoxamine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00278	CcSEcCtD
Carbinoxamine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.00278	CcSEcCtD
Carbinoxamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000401	0.00278	CcSEcCtD
Carbinoxamine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.0004	0.022	CbGeAlD
Carbinoxamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000398	0.00276	CcSEcCtD
Carbinoxamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000396	0.00275	CcSEcCtD
Carbinoxamine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000395	0.00274	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000395	0.00274	CcSEcCtD
Carbinoxamine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000395	0.00274	CcSEcCtD
Carbinoxamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000393	0.00273	CcSEcCtD
Carbinoxamine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00272	CcSEcCtD
Carbinoxamine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000391	0.00271	CcSEcCtD
Carbinoxamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000391	0.00271	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00039	0.0027	CcSEcCtD
Carbinoxamine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000389	0.0027	CcSEcCtD
Carbinoxamine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000389	0.0027	CcSEcCtD
Carbinoxamine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000387	0.00268	CcSEcCtD
Carbinoxamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000386	0.00267	CcSEcCtD
Carbinoxamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000384	0.00267	CcSEcCtD
Carbinoxamine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.00266	CcSEcCtD
Carbinoxamine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000382	0.00265	CcSEcCtD
Carbinoxamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.00263	CcSEcCtD
Carbinoxamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.00261	CcSEcCtD
Carbinoxamine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000377	0.0207	CbGeAlD
Carbinoxamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000375	0.0026	CcSEcCtD
Carbinoxamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00259	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000373	0.00259	CcSEcCtD
Carbinoxamine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000373	0.00258	CcSEcCtD
Carbinoxamine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.00258	CcSEcCtD
Carbinoxamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000372	0.00258	CcSEcCtD
Carbinoxamine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00257	CcSEcCtD
Carbinoxamine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000371	0.00257	CcSEcCtD
Carbinoxamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000371	0.00257	CcSEcCtD
Carbinoxamine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00255	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000368	0.00255	CcSEcCtD
Carbinoxamine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00255	CcSEcCtD
Carbinoxamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000365	0.00253	CcSEcCtD
Carbinoxamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.00253	CcSEcCtD
Carbinoxamine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000365	0.00253	CcSEcCtD
Carbinoxamine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000365	0.00253	CcSEcCtD
Carbinoxamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00252	CcSEcCtD
Carbinoxamine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000362	0.00251	CcSEcCtD
Carbinoxamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00036	0.0025	CcSEcCtD
Carbinoxamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000359	0.00249	CcSEcCtD
Carbinoxamine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000359	0.0197	CbGeAlD
Carbinoxamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000359	0.00249	CcSEcCtD
Carbinoxamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000358	0.00248	CcSEcCtD
Carbinoxamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000358	0.00248	CcSEcCtD
Carbinoxamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000357	0.00248	CcSEcCtD
Carbinoxamine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00248	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000357	0.00247	CcSEcCtD
Carbinoxamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000356	0.00247	CcSEcCtD
Carbinoxamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000355	0.00246	CcSEcCtD
Carbinoxamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000355	0.00246	CcSEcCtD
Carbinoxamine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000355	0.0195	CbGeAlD
Carbinoxamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000354	0.00245	CcSEcCtD
Carbinoxamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00244	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00244	CcSEcCtD
Carbinoxamine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000351	0.0193	CbGeAlD
Carbinoxamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00243	CcSEcCtD
Carbinoxamine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000349	0.0192	CbGeAlD
Carbinoxamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000348	0.00241	CcSEcCtD
Carbinoxamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00241	CcSEcCtD
Carbinoxamine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000346	0.019	CbGeAlD
Carbinoxamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000345	0.00239	CcSEcCtD
Carbinoxamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000345	0.00239	CcSEcCtD
Carbinoxamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000345	0.00239	CcSEcCtD
Carbinoxamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000345	0.00239	CcSEcCtD
Carbinoxamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00237	CcSEcCtD
Carbinoxamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000342	0.00237	CcSEcCtD
Carbinoxamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00237	CcSEcCtD
Carbinoxamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000341	0.00237	CcSEcCtD
Carbinoxamine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00236	CcSEcCtD
Carbinoxamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00236	CcSEcCtD
Carbinoxamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00236	CcSEcCtD
Carbinoxamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000339	0.00235	CcSEcCtD
Carbinoxamine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000338	0.0186	CbGeAlD
Carbinoxamine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000337	0.0185	CbGeAlD
Carbinoxamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00233	CcSEcCtD
Carbinoxamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.00233	CcSEcCtD
Carbinoxamine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000335	0.0184	CbGeAlD
Carbinoxamine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000333	0.0183	CbGeAlD
Carbinoxamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000332	0.0023	CcSEcCtD
Carbinoxamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000331	0.0023	CcSEcCtD
Carbinoxamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000331	0.00229	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00229	CcSEcCtD
Carbinoxamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00033	0.00229	CcSEcCtD
Carbinoxamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00033	0.00229	CcSEcCtD
Carbinoxamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000329	0.00228	CcSEcCtD
Carbinoxamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.00228	CcSEcCtD
Carbinoxamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.00228	CcSEcCtD
Carbinoxamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00228	CcSEcCtD
Carbinoxamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000327	0.00227	CcSEcCtD
Carbinoxamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00227	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.00226	CcSEcCtD
Carbinoxamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000326	0.00226	CcSEcCtD
Carbinoxamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000325	0.00225	CcSEcCtD
Carbinoxamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000324	0.00225	CcSEcCtD
Carbinoxamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00224	CcSEcCtD
Carbinoxamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00223	CcSEcCtD
Carbinoxamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000321	0.00222	CcSEcCtD
Carbinoxamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00222	CcSEcCtD
Carbinoxamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.00221	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000318	0.0022	CcSEcCtD
Carbinoxamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000317	0.0022	CcSEcCtD
Carbinoxamine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000317	0.0174	CbGeAlD
Carbinoxamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.0022	CcSEcCtD
Carbinoxamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00218	CcSEcCtD
Carbinoxamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00218	CcSEcCtD
Carbinoxamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00218	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00217	CcSEcCtD
Carbinoxamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00217	CcSEcCtD
Carbinoxamine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000313	0.0172	CbGeAlD
Carbinoxamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00217	CcSEcCtD
Carbinoxamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000313	0.00217	CcSEcCtD
Carbinoxamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00216	CcSEcCtD
Carbinoxamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.00216	CcSEcCtD
Carbinoxamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00216	CcSEcCtD
Carbinoxamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00214	CcSEcCtD
Carbinoxamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00213	CcSEcCtD
Carbinoxamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000307	0.00213	CcSEcCtD
Carbinoxamine—HRH1—vagina—acquired immunodeficiency syndrome	0.000306	0.0168	CbGeAlD
Carbinoxamine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000305	0.0168	CbGeAlD
Carbinoxamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00211	CcSEcCtD
Carbinoxamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.0021	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000303	0.0021	CcSEcCtD
Carbinoxamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000303	0.0021	CcSEcCtD
Carbinoxamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.0021	CcSEcCtD
Carbinoxamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.00208	CcSEcCtD
Carbinoxamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.00208	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.00207	CcSEcCtD
Carbinoxamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000297	0.00206	CcSEcCtD
Carbinoxamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00206	CcSEcCtD
Carbinoxamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000297	0.00206	CcSEcCtD
Carbinoxamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000296	0.00205	CcSEcCtD
Carbinoxamine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000296	0.0163	CbGeAlD
Carbinoxamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00205	CcSEcCtD
Carbinoxamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000294	0.00203	CcSEcCtD
Carbinoxamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00203	CcSEcCtD
Carbinoxamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000292	0.00202	CcSEcCtD
Carbinoxamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000291	0.00202	CcSEcCtD
Carbinoxamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00202	CcSEcCtD
Carbinoxamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.00201	CcSEcCtD
Carbinoxamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00201	CcSEcCtD
Carbinoxamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00201	CcSEcCtD
Carbinoxamine—HRH1—lung—acquired immunodeficiency syndrome	0.000289	0.0159	CbGeAlD
Carbinoxamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.002	CcSEcCtD
Carbinoxamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000288	0.002	CcSEcCtD
Carbinoxamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00199	CcSEcCtD
Carbinoxamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.00198	CcSEcCtD
Carbinoxamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00196	CcSEcCtD
Carbinoxamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00194	CcSEcCtD
Carbinoxamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00194	CcSEcCtD
Carbinoxamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000278	0.00193	CcSEcCtD
Carbinoxamine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000278	0.0153	CbGeAlD
Carbinoxamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00193	CcSEcCtD
Carbinoxamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.00192	CcSEcCtD
Carbinoxamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00191	CcSEcCtD
Carbinoxamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00191	CcSEcCtD
Carbinoxamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.00191	CcSEcCtD
Carbinoxamine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000274	0.0151	CbGeAlD
Carbinoxamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.0019	CcSEcCtD
Carbinoxamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00189	CcSEcCtD
Carbinoxamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00188	CcSEcCtD
Carbinoxamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00187	CcSEcCtD
Carbinoxamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00186	CcSEcCtD
Carbinoxamine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000268	0.0147	CbGeAlD
Carbinoxamine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000268	0.0147	CbGeAlD
Carbinoxamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00185	CcSEcCtD
Carbinoxamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00185	CcSEcCtD
Carbinoxamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00185	CcSEcCtD
Carbinoxamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.00184	CcSEcCtD
Carbinoxamine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000264	0.0145	CbGeAlD
Carbinoxamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000263	0.0145	CbGeAlD
Carbinoxamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00181	CcSEcCtD
Carbinoxamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00181	CcSEcCtD
Carbinoxamine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000258	0.0142	CbGeAlD
Carbinoxamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00179	CcSEcCtD
Carbinoxamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00179	CcSEcCtD
Carbinoxamine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000257	0.0141	CbGeAlD
Carbinoxamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00178	CcSEcCtD
Carbinoxamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.00177	CcSEcCtD
Carbinoxamine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000255	0.014	CbGeAlD
Carbinoxamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00175	CcSEcCtD
Carbinoxamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00175	CcSEcCtD
Carbinoxamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000251	0.0138	CbGeAlD
Carbinoxamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00173	CcSEcCtD
Carbinoxamine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000248	0.0136	CbGeAlD
Carbinoxamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.0017	CcSEcCtD
Carbinoxamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00168	CcSEcCtD
Carbinoxamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00168	CcSEcCtD
Carbinoxamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00167	CcSEcCtD
Carbinoxamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00024	0.00166	CcSEcCtD
Carbinoxamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00165	CcSEcCtD
Carbinoxamine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000234	0.0128	CbGeAlD
Carbinoxamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00161	CcSEcCtD
Carbinoxamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00161	CcSEcCtD
Carbinoxamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.0016	CcSEcCtD
Carbinoxamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00158	CcSEcCtD
Carbinoxamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000226	0.00157	CcSEcCtD
Carbinoxamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00155	CcSEcCtD
Carbinoxamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00154	CcSEcCtD
Carbinoxamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00154	CcSEcCtD
Carbinoxamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.0015	CcSEcCtD
Carbinoxamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00149	CcSEcCtD
Carbinoxamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00149	CcSEcCtD
Carbinoxamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00147	CcSEcCtD
Carbinoxamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00146	CcSEcCtD
Carbinoxamine—CYP2B6—brain—acquired immunodeficiency syndrome	0.00021	0.0115	CbGeAlD
Carbinoxamine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000207	0.0114	CbGeAlD
Carbinoxamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00143	CcSEcCtD
Carbinoxamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00142	CcSEcCtD
Carbinoxamine—HRH1—brain—acquired immunodeficiency syndrome	0.000205	0.0112	CbGeAlD
Carbinoxamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000204	0.0112	CbGeAlD
Carbinoxamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00141	CcSEcCtD
Carbinoxamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.00139	CcSEcCtD
Carbinoxamine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000199	0.011	CbGeAlD
Carbinoxamine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000198	0.0109	CbGeAlD
Carbinoxamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00136	CcSEcCtD
Carbinoxamine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000197	0.0108	CbGeAlD
Carbinoxamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000196	0.0108	CbGeAlD
Carbinoxamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.00134	CcSEcCtD
Carbinoxamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.00134	CcSEcCtD
Carbinoxamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00127	CcSEcCtD
Carbinoxamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000156	0.00856	CbGeAlD
